246
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Prognostic factors and survival of ALS patients from Belgrade, Serbia

, , , , , & show all
Pages 508-514 | Received 16 Feb 2016, Accepted 25 Apr 2016, Published online: 17 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jinsy A. Andrews, Carlayne E. Jackson, Terry D. Heiman-Patterson, Paolo Bettica, Benjamin Rix Brooks & Erik P. Pioro. (2020) Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 509-518.
Read now
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray & Robert D Henderson. (2020) What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?. Expert Review of Neurotherapeutics 20:9, pages 921-941.
Read now
Imen Kacem, Ikram Sghaier, Sabrine Bougatef, Amina Nasri, Amina Gargouri, Senda Ajroud-Driss & Riadh Gouider. (2020) Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 131-139.
Read now

Articles from other publishers (9)

Christina WolfsonDanielle E. GauvinFoluso IsholaMaryam Oskoui. (2023) Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis. Neurology 101:6.
Crossref
Teresa Pardo-Moreno, Himan Mohamed-Mohamed, Sami Suleiman-Martos, Juan José Ramos-Rodriguez, Antonio Rivas-Dominguez, Lucía Melguizo-Rodríguez, José L. Gómez-Urquiza, Beatriz Bermudez-Pulgarin & Victoria Garcia-Morales. (2023) Amyotrophic Lateral Sclerosis and Serum Lipid Level Association: A Systematic Review and Meta-Analytic Study. International Journal of Molecular Sciences 24:10, pages 8675.
Crossref
Recep YEVGİ & Nuray BİLGE. (2021) Clinical and epidemiological features of amyotrophic lateral sclerosis in eastern Turkey. Journal of Health Sciences and Medicine 4:5, pages 576-581.
Crossref
Danielle Richards, John A. Morren & Erik P. Pioro. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis 15 34 .
Qian-Qian Wei, Ruwei Ou, Bei Cao, Yongping Chen, Yanbing Hou, Lingyu Zhang, Fanyi Wu & Huifang Shang. (2021) Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis. Brain Research Bulletin 171, pages 10-15.
Crossref
Martin Matharan, Stéphane Mathis, Sarah Bonabaud, Louis Carla, Antoine Soulages & Gwendal Le Masson. (2020) Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners. Neurology Research International 2020, pages 1-8.
Crossref
Igor Lepir, Milica Malešević & Aleksandra Dominović-Kovačević. (2019) Clinical characteristics of patients with Amyotrophic Lateral Sclerosis in the Republic of Srpska. Medicinski podmladak 70:2, pages 24-29.
Crossref
Qian-Qian Wei, Yongping Chen, Xueping Chen, Bei Cao, RuWei Ou, Lingyu Zhang, Yanbing Hou & Huifang Shang. (2018) Clinical and prognostic features of ALS/MND in different phenotypes–data from a hospital-based registry. Brain Research Bulletin 142, pages 403-408.
Crossref
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.